Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R.F. Smith(Inovio Pharmaceuticals (United States)), Jason S. McLellan(The University of Texas at Austin), Daniel H. Park(The Wistar Institute), Jiangning Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jacqueline D. Chu(The Wistar Institute), Ziyang Xu(The Wistar Institute), Katherine Schultheis(Inovio Pharmaceuticals (United States)), Nicholas J. Tursi(The Wistar Institute), Miguel Vasquez(Inovio Pharmaceuticals (United States)), Patrick Pezzoli(Inovio Pharmaceuticals (United States)), Susanne N. Walker(The Wistar Institute), Makan Khoshnejad(The Wistar Institute), Igor Maricic(Inovio Pharmaceuticals (United States)), Xizhou Zhu(The Wistar Institute), Timothy A. Herring(Inovio Pharmaceuticals (United States)), Alison Generotti(Inovio Pharmaceuticals (United States)), Pratik Bhojnagarwala(The Wistar Institute), Ami Shah Brown(Inovio Pharmaceuticals (United States)), Gan Zhao(Children's Hospital of Philadelphia), Edgar Tello‐Ruiz(The Wistar Institute), E. Gary(The Wistar Institute), Kevin Y. Kim(The Wistar Institute), Dinah Amante(Inovio Pharmaceuticals (United States)), Yaya Dia(The Wistar Institute), Daniel Wrapp(Duke University), Mansi Purwar(The Wistar Institute), Ami Patel(ICAR-Indian Institute of Agricultural Biotechnology), Emma L. Reuschel(The Wistar Institute), Yuanhan Wu(The Wistar Institute), Mamadou A. Bah(The Wistar Institute), Neethu Chokkalingam(The Wistar Institute), Stephanie Ramos(Inovio Pharmaceuticals (United States)), Dustin Elwood(Inovio Pharmaceuticals (United States)), Jihae Choi(The Wistar Institute), Linlin Bao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian Yan(Inovio Pharmaceuticals (United States)), Wei Deng(Wuhan Institute of Virology), Nianshuang Wang(The University of Texas at Austin), Chuan Qin(Chinese Academy of Medical Sciences & Peking Union Medical College), Elizabeth M. Parzych(The Wistar Institute), Faraz I. Zaidi(The Wistar Institute), Ali Raza Ali(The Wistar Institute), Viviane M. Andrade(Inovio Pharmaceuticals (United States)), Sophia M. Reeder(The Wistar Institute), Dan Li(Shanghai Jiao Tong University), Maria Yang(Inovio Pharmaceuticals (United States)), Karen R. Buttigieg(Bradford Teaching Hospitals NHS Foundation Trust), Jewell Walters(Inovio Pharmaceuticals (United States)), Arthur Doan(Inovio Pharmaceuticals (United States)), Jiun-Ming Wu
Cited by 641
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k